UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-26 | Future report Set alerts | |
| Q2 2022 | 2022-08-04 | -0.80 | -0.80 |
| Q1 2022 | 2022-05-05 | -0.80 | -0.80 |
| Q4 2021 | 2022-02-17 | -0.95 | -0.95 |
| Q3 2021 | 2021-10-28 | -0.96 | -0.96 |
| Q2 2021 | 2021-08-05 | -1.07 | -1.07 |
| Q1 2021 | 2021-05-06 | -0.89 | -0.89 |
| Q4 2020 | 2021-02-25 | -1.00 | -1.00 |
| Q3 2020 | 2020-10-29 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-06 | -0.64 | -0.64 |
| 2016-06-15 | Reiterated Rating | HC Wainwright | Buy | |
| 2016-06-09 | Reiterated Rating | Piper Jaffray | Overweight | $24.00 |
| 2016-06-09 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $24.00 |
| 2016-04-17 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-03-16 | Lower Price Target | Citigroup Inc. | Neutral | $21.00 to $13.00 |
| 2016-03-15 | Initiated Coverage | Stifel Nicolaus | Buy | $23.00 |
| 2016-02-26 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-02-26 | Lower Price Target | Leerink Swann | Outperform | $29.00 to $23.00 |
| 2016-01-07 | Reiterated Rating | Piper Jaffray | Overweight | $41.00 to $29.00 |
| 2015-11-09 | Reiterated Rating | Cowen and Company | Outperform | $38.00 to $34.00 |
| 2015-10-06 | Boost Price Target | HC Wainwright | Buy | $30.00 to $35.00 |
| 2015-10-06 | Reiterated Rating | Leerink Swann | Outperform | |
| 2015-09-23 | Reiterated Rating | Piper Jaffray | Buy | |
| 2015-06-09 | Initiated Coverage | Citigroup Inc. | Neutral | $27.00 |
| 2015-05-11 | Boost Price Target | Cowen and Company | Outperform | $20.00 to $25.00 |
| 2015-03-23 | Set Price Target | Piper Jaffray | Buy | $51.00 |
| 2015-02-09 | Initiated Coverage | Janney Montgomery Scott | Buy | $33.00 |
| 2014-09-05 | Initiated Coverage | Cowen and Company | Outperform | $20.00 |
| 2014-04-23 | Boost Price Target | Piper Jaffray | Overweight | $14.00 to $51.00 |
| 2014-03-31 | Reiterated Rating | Wedbush | Underperform | $7.00 |
| 2014-03-26 | Boost Price Target | HC Wainwright | Buy | $25.00 to $30.00 |
| 2014-02-18 | Set Price Target | Piper Jaffray | $34.00 to $45.00 | |
| 2014-02-11 | Downgrade | Wedbush | Outperform to Underperform | $18.00 to $7.00 |
| 2014-01-09 | Upgrade | JMP Securities | Market Perform to Outperform | $25.00 |
| 2013-11-26 | Initiated Coverage | Piper Jaffray | Overweight | $34.00 |
| 2013-11-11 | Initiated Coverage | HC Wainwright | Buy | $25.00 |
| 2013-10-17 | Initiated Coverage | JMP Securities | Market Perform | |
| 2013-06-19 | Initiated | UBS | Buy | $17.50 |
| 2013-06-18 | Initiated | UBS | Buy | $17.50 |
| 2011-09-16 | Initiated | Wedbush | Outperform | $15 |
| 2016-06-15 | Reiterated Rating | HC Wainwright | Buy | |
| 2016-06-09 | Reiterated Rating | Piper Jaffray | Overweight | $24.00 |
| 2016-06-09 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $24.00 |
| 2016-04-17 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-03-16 | Lower Price Target | Citigroup Inc. | Neutral | $21.00 to $13.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In INSM 177 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 11.35M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 9.55M |
| BlackRock Inc. | 9.26M |
| Palo Alto Investors, LLC | 5.84M |
| STATE STREET CORP | 5.45M |
| MACQUARIE GROUP LTD | 3.56M |
| FMR LLC | 3.55M |
| FRANKLIN RESOURCES INC | 3.51M |
| HENDERSON GROUP PLC | 3.42M |
| AMERIPRISE FINANCIAL INC | 2.91M |
| JANUS CAPITAL MANAGEMENT LLC | 2.81M |
| BlackRock Fund Advisors | 2.71M |
| PICTET ASSET MANAGEMENT LTD | 2.55M |
| ALLIANCEBERNSTEIN L.P. | 2.51M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.14M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| ENGELSEN STEINAR J | 0.66% (259152) | CAPN / INSM / |
| SHAROKY MELVIN MD | 0.57% (225728) | INSM / |
| Lewis William President and CEO | 0.35% (135547) | INSM / QURE / |
| WHITCOMB RANDALL W | 0.18% (69188) | INSM / |
| HAYDEN DONALD J JR | 0.14% (56131) | FOLD / INSM / VTAE / |
| Drucker Andrea Holtzman Senior V.P., General Counsel | 0.11% (45000) | INSM / |
| Brennan David R | 0.11% (42256) | INSM / |
| ALTOMARI ALFRED | 0.11% (41876) | AGRX / INSM / REPH / |
| Pellizzari Christine A General Counsel & Secretary | 0.10% (40669) | INSM / |
| GUPTA RENU Chief Medical Officer | 0.09% (37014) | INSM / |
| MCGIRR DAVID W J | 0.07% (29296) | INSM / RLYP / ROKA / |
| Kollender Richard S | 0.06% (24598) | CPXX / INSM / PATH / |
| POTTER MYRTLE S | 0.05% (19444) | EVDY / INSM / RAD / |
| Adsett Roger Chief Commercial Officer | 0.04% (15594) | INSM / |
| Drechsler Andrew T Chief Financial Officer | 0.04% (15000) | INSM / |
| STRECK PAUL Chief Medical Officer | 0.03% (11490) | INSM / |
| TOMBESI PAOLO Chief Financial Officer | 0.03% (10669) | INSM / |
| Schaeffer Orlov S Nicole SVP, HR & Corp. Svcs. | 0.03% (10669) | INSM / |
| Whitten Timothy President & CEO | 0.03% (10000) | INSM / |
| FMR LLC Edward C. Johnson 3d | 0.01% (2221) | EXA / GNRC / GTAT / INSM / IRWD / MNLO / SURF / TTPH / XOOM / |
UM